drug summary · 2 NDC codes
Jadenu 90 mg/1
deferasirox
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | deferasirox |
|---|---|
| active ingredients | DEFERASIROX |
| dosage form | GRANULE |
| route | ORAL |
| strength | 90 mg/1 |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA207968 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Novartis Pharmaceuticals Corporation |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00078072715 | — |
| 0078-0727 | — |
Other deferasirox products
5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Jadenu 180 mg/1GRANULE · Novartis Pharmaceuticals Corporation
- Jadenu 180 mg/1TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
- Jadenu 360 mg/1GRANULE · Novartis Pharmaceuticals Corporation
- Jadenu 360 mg/1TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
- Jadenu 90 mg/1TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.